apnea has been researched along with Morbid Obesity in 17 studies
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the duration of safe apnea using high-flown nasal insufflation of oxygen or standard flow oxygen insufflation for apneic oxygenation in a simulated difficult intubation scenario in patients with morbid obesity." | 9.41 | Duration of safe apnea in patients with morbid obesity during passive oxygenation using high-flow nasal insufflation versus regular flow nasal insufflation, a randomized trial. ( Baron-Stefaniak, J; Bichler, C; Hamp, T; Müller, J; Plöchl, W; Prager, G, 2021) |
| " High-flow nasal oxygenation use during anesthesia induction prolongs safe apnea time in nonobese surgical patients." | 9.30 | High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial. ( Chung, F; Dallaire, A; Jackson, T; Madhusudan, P; Singh, KP; Singh, M; Wong, DT; Wong, J, 2019) |
| "The mean safe apnea time was 205 (96-320)s in FM vs." | 9.17 | ProSeal™ LMA increases safe apnea period in morbidly obese patients undergoing surgery under general anesthesia. ( Jayaraman, L; Punhani, D; Sinha, A, 2013) |
| "Positive end-expiratory pressure (PEEP) applied during induction of anesthesia prevents atelectasis formation and increases the duration of nonhypoxic apnea in nonobese patients." | 9.11 | Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. ( Frascarolo, P; Gander, S; Magnusson, L; Spahn, DR; Suter, M, 2005) |
| "Obese patients have a decreased functional residual capacity and, hence, a reduced oxygen supply during periods of apnea." | 7.68 | Effect of obesity on safe duration of apnea in anesthetized humans. ( Dubin, SA; Jense, HG; O'Leary-Escolas, U; Silverstein, PI, 1991) |
| "To compare the duration of safe apnea using high-flown nasal insufflation of oxygen or standard flow oxygen insufflation for apneic oxygenation in a simulated difficult intubation scenario in patients with morbid obesity." | 5.41 | Duration of safe apnea in patients with morbid obesity during passive oxygenation using high-flow nasal insufflation versus regular flow nasal insufflation, a randomized trial. ( Baron-Stefaniak, J; Bichler, C; Hamp, T; Müller, J; Plöchl, W; Prager, G, 2021) |
| " High-flow nasal oxygenation use during anesthesia induction prolongs safe apnea time in nonobese surgical patients." | 5.30 | High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial. ( Chung, F; Dallaire, A; Jackson, T; Madhusudan, P; Singh, KP; Singh, M; Wong, DT; Wong, J, 2019) |
| "The mean safe apnea time was 205 (96-320)s in FM vs." | 5.17 | ProSeal™ LMA increases safe apnea period in morbidly obese patients undergoing surgery under general anesthesia. ( Jayaraman, L; Punhani, D; Sinha, A, 2013) |
| "To compare two techniques of preoxygenation, eight deep breaths (8DB) and tidal volume breathing in obese patients by measuring end-tidal fractional oxygen concentration (FETO2) and apnea time from 100% of hemoglobin saturation to 95% (T95%)." | 5.11 | [Comparison of eight deep breaths and tidal volume breathing preoxygenation techniques in morbid obese patients]. ( Bazin, R; Janvier, G; Joannes-Boyau, O; Rapaport, S, 2004) |
| "Positive end-expiratory pressure (PEEP) applied during induction of anesthesia prevents atelectasis formation and increases the duration of nonhypoxic apnea in nonobese patients." | 5.11 | Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. ( Frascarolo, P; Gander, S; Magnusson, L; Spahn, DR; Suter, M, 2005) |
| " First of all, some features of the so called metabolic syndrome; furthermore, hormonal alteration during and after puberty, genital appearance in the obese adolescent male, respiratory problems as apnea, asthma, and the Pickwick syndrome." | 4.84 | [Obesity in adolescents: physical correlated pathologies, and therapeutic state of art]. ( Giorgi, PL, 2007) |
| " He had seizures attacks and apnea from the second week of his life." | 3.78 | Early-onset severe obesity with ACTH deficiency and red hair in a boy: the POMC deficiency. ( Aldemir, O; Ozen, S, 2012) |
| "Because LMA CTrach promoted short apnea time and the Airtraq laryngoscope allowed early definitive airway, both video-assisted tracheal intubation devices prevented most serious arterial oxygenation desaturation evidenced during tracheal intubation of morbidly obese patients with the conventional Macintosh laryngoscope." | 3.75 | Video-assisted versus conventional tracheal intubation in morbidly obese patients. ( Abdi, W; Amathieu, R; Champault, G; Combes, X; Dhonneur, G; El Housseini, L; Ndoko, SK; Polliand, C; Risk, N; Tual, L, 2009) |
| "Obese patients have a decreased functional residual capacity and, hence, a reduced oxygen supply during periods of apnea." | 3.68 | Effect of obesity on safe duration of apnea in anesthetized humans. ( Dubin, SA; Jense, HG; O'Leary-Escolas, U; Silverstein, PI, 1991) |
| "Morbid obesity is associated with a reduction in time to desaturate during apnoea following standard pre-oxygenation and induction of anaesthesia." | 2.70 | Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women. ( Berthoud, MC; Cressey, DM; Reilly, CS, 2001) |
| "Labour, morbid obesity and sepsis accelerated pre-oxygenation and de-oxygenation during apnoea." | 1.35 | Pre-oxygenation and apnoea in pregnancy: changes during labour and with obstetric morbidity in a computational simulation. ( Bogod, DG; Hardman, JG; McClelland, SH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Schutzer-Weissmann, J | 1 |
| Wojcikiewicz, T | 1 |
| Karmali, A | 1 |
| Lukosiute, A | 1 |
| Sun, R | 1 |
| Kanji, R | 1 |
| Ahmed, AR | 1 |
| Purkayastha, S | 1 |
| Brett, SJ | 1 |
| Cousins, J | 1 |
| Pierpoint, SA | 1 |
| Burke, JL | 1 |
| Schober, P | 1 |
| Vetter, TR | 1 |
| Wong, DT | 1 |
| Dallaire, A | 1 |
| Singh, KP | 1 |
| Madhusudan, P | 1 |
| Jackson, T | 1 |
| Singh, M | 1 |
| Wong, J | 1 |
| Chung, F | 1 |
| Hamp, T | 1 |
| Prager, G | 1 |
| Baron-Stefaniak, J | 1 |
| Müller, J | 1 |
| Bichler, C | 1 |
| Plöchl, W | 1 |
| Ozen, S | 1 |
| Aldemir, O | 1 |
| Dhonneur, G | 1 |
| Abdi, W | 1 |
| Ndoko, SK | 1 |
| Amathieu, R | 1 |
| Risk, N | 1 |
| El Housseini, L | 1 |
| Polliand, C | 1 |
| Champault, G | 1 |
| Combes, X | 1 |
| Tual, L | 1 |
| Baraka, A | 1 |
| McClelland, SH | 1 |
| Bogod, DG | 1 |
| Hardman, JG | 1 |
| Boisson-Bertrand, D | 1 |
| Sinha, A | 1 |
| Jayaraman, L | 1 |
| Punhani, D | 1 |
| Rapaport, S | 1 |
| Joannes-Boyau, O | 1 |
| Bazin, R | 1 |
| Janvier, G | 1 |
| Gander, S | 1 |
| Frascarolo, P | 1 |
| Suter, M | 1 |
| Spahn, DR | 1 |
| Magnusson, L | 1 |
| Giorgi, PL | 1 |
| Solis, A | 1 |
| Baillard, C | 1 |
| Cressey, DM | 1 |
| Berthoud, MC | 1 |
| Reilly, CS | 1 |
| Jense, HG | 1 |
| Dubin, SA | 1 |
| Silverstein, PI | 1 |
| O'Leary-Escolas, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Controlled Comparison of Effectiveness of Facemask Preoxygenation and Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) in Bariatric Patients Undergoing General Anaesthesia[NCT03428256] | 80 participants (Actual) | Interventional | 2018-10-01 | Completed | |||
| Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Apnoeic Ventilation During Operative Hysteroscopic Procedures Under General Anesthesia: an Observational Study.[NCT05291117] | 30 participants (Actual) | Observational | 2022-02-01 | Completed | |||
| Effectiveness of Apneic Oxygenation Using High-flow Nasal Cannula in Morbidly Obese Patients Undergoing General Anesthesia[NCT03195504] | 40 participants (Actual) | Interventional | 2017-08-10 | Completed | |||
| High Flow Oxygen During ProcEdural Sedation for Operative Hysteroscopy: a Randomized Controlled Trial - HOPE Study.[NCT05550584] | 180 participants (Actual) | Interventional | 2022-06-17 | Completed | |||
| "A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"[NCT02943629] | 0 participants (Actual) | Interventional | 2016-11-30 | Withdrawn (stopped due to Lack of feasibility) | |||
| Preoxygenation With Optiflow™, a High Flow Nasal Cannula (HFNC), is Superior to Preoxygenation With Facemask in Morbidly Obese Patients Undergoing General Anesthesia[NCT03009877] | 0 participants (Actual) | Interventional | 2018-07-31 | Withdrawn (stopped due to withdrawn prior to IRB approval) | |||
| Efficiency of Preoxygenation in Obese Patients: Evaluation of Traditional Method Versus Pressure Assisted Preoxygenation.[NCT00673634] | 30 participants (Actual) | Interventional | 2008-03-31 | Completed | |||
| EPO2-A: Evaluation of Different Pre-Oxygenation Condition in Morbid Obesity: Effect of Position and Positive Pressure Ventilation During General Anesthesia Induction[NCT02590406] | 50 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| Does Pulmonary Compliance Optimization Through PEEP Manipulations Reduces the Incidence of Postoperative Hypoxaemia in Bariatric Surgery?[NCT02579798] | 100 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Evaluation of Different Pre-Oxygenation Conditions in Morbid Obesity: Position and Ventilation Mode, in a Respiratory Physiology Laboratory, on Voluntary Subjects[NCT02121808] | 20 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| Apneic Oxygenation With a Nasal Cannula in the Obese and Morbidly Obese Surgical Patient: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT03671837] | 135 participants (Actual) | Interventional | 2017-07-12 | Completed | |||
| Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients[NCT03021551] | 80 participants (Actual) | Interventional | 2016-09-15 | Completed | |||
| Effect of the Duration of Pre-oxygenation (3 Minutes vs 6 Minutes) on Apnea Tolerance in Obese Patients (BMI> 30 kg / m2) During the Induction of General Anesthesia[NCT04699435] | 200 participants (Anticipated) | Interventional | 2021-01-13 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluation of the maximum expired oxygen fraction obtained in the two groups (NCT02590406)
Timeframe: After 3 minutes of pre-oxygenation
| Intervention | Maximum expired fraction of oxygen obtai (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 0.89 |
| Reverse Trendelenburg and NIPPV | 0.91 |
Evaluation of the minimal saturation obtained after the resumption of the ventilation (NCT02590406)
Timeframe: After the end of the Non-hypoxic apnea time
| Intervention | percent (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 83.6 |
| Reverse Trendelenburg and NIPPV | 85.3 |
Change of Non-hypoxic apnea time in obese patient during a General Anesthesia induction, as a result of different pre-oxygenation position and ventilation mode; 1-Beach Chair and No positive pressure ventilation, 2-Reverse Trendelenburg and positive pressure ventilation and PEEP. End of measure time frame is 5 minutes after intubation (NCT02590406)
Timeframe: After a 3 minutes pre-oxygenation period
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 216.7 |
| Reverse Trendelenburg and NIPPV | 258.2 |
(NCT02590406)
Timeframe: Evaluation of the time needed to the beginning of the ventilation to the moment where the saturation is 97%
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 88.4 |
| Reverse Trendelenburg and NIPPV | 68 |
Evaluation of time needed to obtain an expired fraction of oxygen of > 0,9 in the two groups during the pre-oxygenation (NCT02590406)
Timeframe: During the pre-oxygenation period
| Intervention | seconds (Mean) |
|---|---|
| Beach Chair (BC) and ZEEP | 145.3 |
| Reverse Trendelenburg and NIPPV | 85.1 |
Change of functional residual capacity (FRC), in obese patient, as a result of different pre-oxygenation positions; 1- supine, 2-beach-chair, 3- reverse Trendelenburg, in two different ventilation modes : 1- spontaneous ventilation at tidal volume, 2- non-invasive positive pressure ventilation with inspiratory assistance. (NCT02121808)
Timeframe: After a 5 minutes pre-oxygenation period
| Intervention | ml (Mean) |
|---|---|
| 1. Supine + NIPPV | 2573 |
| 2. Supine + Tidal Volume Spontaneous Ventilation | 2145 |
| 3. Beach Chair (Back 25 Deg) + NIPPV | 2456 |
| 4. Beach Chair (Back 25 Deg) + Tidal Volume Spontaneous Ventil | 2219 |
| 5. Proclive (Global 25 Deg) + NIPPV | 2684 |
| 6. Proclive (Global 25 Deg) + Tidal Volume Spontaneous Ventila | 2282 |
Evaluate the clinical utility of the change in the oxygen reserve index as an early warning of impending arterial oxygen desaturation in Obese patients (30 < BMI < 40 kg m-2) and Normal BMI patients (19 < BMI < 25 kg m-2). (NCT03021551)
Timeframe: 1 year
| Intervention | seconds (Number) | |
|---|---|---|
| Added warning time in Obese | Added warning time in Normal BMI | |
| Rainbow Sensor | 46.5 | 87.0 |
1 review available for apnea and Morbid Obesity
| Article | Year |
|---|---|
[Obesity in adolescents: physical correlated pathologies, and therapeutic state of art].
Topics: Adolescent; Adult; Age Factors; Apnea; Bariatric Surgery; Bariatrics; Body Mass Index; Cardiovascula | 2007 |
8 trials available for apnea and Morbid Obesity
| Article | Year |
|---|---|
Apnoeic oxygenation in morbid obesity: a randomised controlled trial comparing facemask and high-flow nasal oxygen delivery.
Topics: Administration, Intranasal; Apnea; Humans; Masks; Obesity, Morbid; Oxygen; Oxygen Inhalation Therapy | 2023 |
Comparing nasopharyngeal apnoeic oxygenation at 18 l/min to preoxygenation alone in obese patients - A randomised controlled study.
Topics: Adult; Apnea; Humans; Nasopharynx; Obesity, Morbid; Oxygen; Oxygen Inhalation Therapy; Respiration, | 2023 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.
Topics: Administration, Intranasal; Adult; Anesthesia, General; Apnea; Biomarkers; Body Mass Index; Female; | 2019 |
Duration of safe apnea in patients with morbid obesity during passive oxygenation using high-flow nasal insufflation versus regular flow nasal insufflation, a randomized trial.
Topics: Apnea; Humans; Insufflation; Intubation, Intratracheal; Laryngoscopy; Obesity, Morbid; Prospective S | 2021 |
ProSeal™ LMA increases safe apnea period in morbidly obese patients undergoing surgery under general anesthesia.
Topics: Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Body Mass Index; Equipment Design; Female; Hu | 2013 |
[Comparison of eight deep breaths and tidal volume breathing preoxygenation techniques in morbid obese patients].
Topics: Adult; Anesthesia, Inhalation; Apnea; Body Mass Index; Female; Hematocrit; Hemoglobins; Humans; Male | 2004 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.
Topics: Adolescent; Adult; Anesthesia, General; Apnea; Blood Gas Analysis; Female; Humans; Male; Middle Aged | 2005 |
Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women.
Topics: Adult; Anesthesia, General; Apnea; Blood Pressure; Body Mass Index; Female; Heart Rate; Humans; Intu | 2001 |
8 other studies available for apnea and Morbid Obesity
| Article | Year |
|---|---|
Two-Sample Unpaired t Tests in Medical Research.
Topics: Anesthesia, General; Apnea; Biomedical Research; Humans; Obesity, Morbid; Oxygen | 2019 |
Early-onset severe obesity with ACTH deficiency and red hair in a boy: the POMC deficiency.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Apnea; Caloric Restric | 2012 |
Video-assisted versus conventional tracheal intubation in morbidly obese patients.
Topics: Adolescent; Adult; Apnea; Bariatric Surgery; Equipment Design; Female; Humans; Intubation, Intratrac | 2009 |
Professor Martin H: son Holmdahl.
Topics: Anesthesia, Inhalation; Anesthesiology; Apnea; Bronchoscopy; Diffusion; History, 20th Century; Leban | 2008 |
Pre-oxygenation and apnoea in pregnancy: changes during labour and with obstetric morbidity in a computational simulation.
Topics: Anesthesia, General; Anesthesia, Obstetrical; Apnea; Body Mass Index; Cesarean Section; Computer Sim | 2009 |
[The 24th meeting of the Club d'Anesthésie-Réanimation en ORL ].
Topics: Anesthesiology; Apnea; Dyspnea; Emergency Medical Services; Female; Humans; Intubation, Intratrachea | 2011 |
[Effectiveness of preoxygenation using the head-up position and noninvasive ventilation to reduce hypoxaemia during intubation].
Topics: Adult; Anesthesia, General; Apnea; Critical Illness; Female; Humans; Hypoxia; Intubation, Intratrach | 2008 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |